Your search returned 3 results.

Results
	1.	Initial testing (stage 1) of M6620 (formerly VX-970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program. [electronic resource] by Kurmasheva, Raushan T Kurmashev, Dias Reynolds, C Patrick Kang, Min Wu, Jianwrong Houghton, Peter J Smith, Malcolm A Producer: 20171227 In: Pediatric blood & cancer vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program. [electronic resource] by Kurmasheva, Raushan T Sammons, Melissa Favours, Edward Wu, Jianwrong Kurmashev, Dias Cosmopoulos, Katherine Keilhack, Heike Klaus, Christine R Houghton, Peter J Smith, Malcolm A Producer: 20170621 In: Pediatric blood & cancer vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Initial Testing (Stage 1) of MK-8242-A Novel MDM2 Inhibitor-by the Pediatric Preclinical Testing Program. [electronic resource] by Kang, Min H Reynolds, C Patrick Kolb, E Anders Gorlick, Richard Carol, Hernan Lock, Richard Keir, Stephen T Maris, John M Wu, Jianwrong Lyalin, Dmitry Kurmasheva, Raushan T Houghton, Peter J Smith, Malcolm A Producer: 20170623 In: Pediatric blood & cancer vol. 63 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)